October 13, 2017 - ZOLL Showcases New Ventilator Capabilities at AMTC 2017

MEDIA CONTACT:

Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637
degan@zoll.com

 

 

ZOLL SHOWCASES NEW VENTILATOR CAPABILITIES AT AMTC 2017

October 13, 2017—CHELMSFORD, MASS.—ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, will offer Air Medical Transport Conference 2017 (AMTC) attendees the opportunity to experience the new capabilities of its mechanical ventilation devices in booth 901 October 16-18 at the Fort Worth Convention Center in Fort Worth, Texas.

Respiratory Care—Launching New Capabilities

Using ZOLL’s EMV+® Ventilator, participants will experience firsthand how lungs adapt to each ventilator mode. With its unique Smart Help technology, ZOLL ventilators provide on-screen prompts to guide users through alarm resolution. In addition, the EMV+ Ventilator is altitude compensated from -2,000 feet up to 25,000 feet (-610 meters to 7,620 meters), which is particularly valuable when transporting patients in flight.

ZOLL will also showcase new additional capabilities in the EMV+ that include inverse I:E ratio as well as plateau pressure measurement, allowing the air medical community to provide more tailored patient care for high-acuity patients such as acute respiratory distress syndrome (ARDS).

Addressing Air Medical Transport Needs

The ZOLL X Series® Monitor/Defibrillator, built on an expandable platform, addresses air medical transport needs now and moving forward. Weighing less than 12 pounds (6 kilograms), it delivers the capabilities of a full-featured monitor designed for use with all patients, ranging from neonates through adults.

It features Real CPR Help®, which in conjunction with scenario-based training, nearly triples the likelihood of patients surviving cardiac arrest1 and ZOLL’s proprietary See-Thru CPR® to let rescuers reduce interruptions in chest compressions by allowing them see underlying heart rhythms without pausing. Open 12-lead capabilities reduce time-to-balloon by interfacing with all leading ECG management and STEMI systems. Cutting-edge open communication, including integrated WiFi, simplifies transmission and charting.

Resuscitation on the Move

Designed for Resuscitation on the Move™, the AutoPulse® Resuscitation System allows air medical transport providers to continue providing high-quality CPR while in flight due to the low-profile design of the AutoPulse, making it the ideal automated CPR system for helicopter transport. A recent study showed that the AutoPulse had a significant survival benefit compared to manual CPR when resuscitation efforts lasted longer than 16 minutes.2 In a meta-analysis of 12 comparative clinical trials, the AutoPulse improved the odds of return of spontaneous circulation (ROSC) by 62% when compared to manual CPR.3

ResQCPR System

Also on display is the ResQCPR™ System, which utilizes active compression-decompression CPR (ACD-CPR) and an impedance threshold device (ITD), to improve blood flow to vital organs and increase the likelihood that patients will survive sudden cardiac arrest.4,5 The two-device combination was shown in a large clinical trial to improve survival to one year from out-of-hospital, non-traumatic cardiac arrest by 49% when compared to treatment with conventional cardiopulmonary resuscitation (CPR).5

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group Company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the material, homes, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.

1Bobrow BJ, et al. Ann Emerg Med. 2013 Jul;62(1):47–56.e1.
2Olsen JA, et al. Acta Anaesthesiologica Scandinavica. 2015;60:222–229.
3Westfall M, et al. Crit Care Med. 2013 Jul;41(7):1782–89.
4Metzger A, et al. Crit Care Med. 2012;40(6):1851–56.
5ResQCPR System Summary of Safety and Effectiveness Data approved by Food and Drug Administration 2015.

Copyright © 2017 ZOLL Medical Corporation. All rights reserved. AutoPulse, EMV+, Real CPR Help, Resuscitation on the Move, ResQCPR, See-Thru CPR, Smart Help, X Series, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All other trademarks are the property of their respective owners.